---
figid: PMC8140811__po-5-po.20.00086-g012
figtitle: Protein Signature Predicts Response to Neoadjuvant Treatment With Chemotherapy
  and Bevacizumab in HER2-Negative Breast Cancers
organisms:
- NA
pmcid: PMC8140811
filename: po-5-po.20.00086-g012.jpg
figlink: /pmc/articles/PMC8140811/figure/figA7/
number: F7
caption: In silico predicted downstream biological effects of bevacizumab treatment
  mediated through the ViRP proteins. In silico simulation with Ingenuity Pathway
  Analysis (version 47547484, Qiagen) was used to predict biologic effects (lower
  row) affected by the ViRP member proteins (second bottom row) when influenced by
  bevacizumab treatment (top row) through a set of intermediate proteins (second top
  row). Red or orange color predicts activation, blue color indicates inhibition,
  and yellow color indicates findings inconsistent with the state of downstream molecule.
  ViRP, VEGF inhibition response predictor.
papertitle: Protein Signature Predicts Response to Neoadjuvant Treatment With Chemotherapy
  and Bevacizumab in HER2-Negative Breast Cancers.
reftext: Mads H. Haugen, et al. JCO Precis Oncol. 2021;5:PO.20.00086.
year: '2021'
doi: 10.1200/PO.20.00086
journal_title: JCO Precision Oncology
journal_nlm_ta: JCO Precis Oncol
publisher_name: American Society of Clinical Oncology
keywords: ''
automl_pathway: 0.9328232
figid_alias: PMC8140811__F7
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC8140811__F7
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8140811__po-5-po.20.00086-g012.html
  '@type': Dataset
  description: In silico predicted downstream biological effects of bevacizumab treatment
    mediated through the ViRP proteins. In silico simulation with Ingenuity Pathway
    Analysis (version 47547484, Qiagen) was used to predict biologic effects (lower
    row) affected by the ViRP member proteins (second bottom row) when influenced
    by bevacizumab treatment (top row) through a set of intermediate proteins (second
    top row). Red or orange color predicts activation, blue color indicates inhibition,
    and yellow color indicates findings inconsistent with the state of downstream
    molecule. ViRP, VEGF inhibition response predictor.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PGF
  - ANGPT1
  - TP53BP1
  - ANGPT2
  - ACACA
  - FN1
  - NRP1
  - NELL1
  - MYH9
  - CXCR4
  - BCL2
  - CXCL12
  - EGFR
  - NOTCH1
  - VEGFA
  - SYK
  - VEGFB
  - VEGFC
  - VEGFD
  - CHEK1
  - KDR
  - NDRG1
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - TGFA
  - GNAO1
  - GNAI1
  - GNAI2
  - GNAI3
  - GNAT1
  - GNAT2
  - GNAT3
  - GNAZ
  - GNAS
  - GNAL
  - GNAQ
  - GNA11
  - GNA14
  - GNA15
  - GNA12
  - GNA13
---
